BioCentury
ARTICLE | Financial News

Chipscreen set to test Shanghai’s new innovation board

June 7, 2019 10:49 PM UTC

Chipscreen could soon become the first biotech to list on the Shanghai Stock Exchange’s new science and technology innovation board after its application was approved this week.

The application from Shenzhen Chipscreen Biosciences Ltd. (Shenzhen, China), one of three approved this week, is moving rapidly compared with approvals for Shanghai’s main board. The innovation board accepted Chipscreen's listing application on March 27 and approved it on June 5. The China Securities Regulatory Commission (CSRC) has 20 days to decide whether to register the application. Listings on the main board must be approved directly by the commission, a process that can take up to four years...